Speaking of challenge trials

Speaking of challenge trials . . .this panel that I recently moderated for Duke Science & Society is quite informative, I think. It features Marc Lipsitch, who is a professor of epidemiology, immunology and infectious disease at the Harvard TH Chan School of Public Health, and the director of the Center for Communicable Disease Dynamics; Nir Eyal, a professor of bioethics at the Rutgers School of Public Health, and the Director of the Center for Population–Level Bioethics at Rutgers; and Cameron Wolfe, an Associate Professor of Medicine and clinical expert in respiratory and infectious disease at the Duke Medical School and Duke Hospital, where he has been treating COVID-19 patients since they began to be admitted to our hospital system this spring.